Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Leiden collaboration enhances drug discovery for membrane proteins
A joint effort between Leiden University’s Professor Ubbink’s lab and ZoBio’s Assay Development and Screening team has advanced fragment-based drug discovery targeting membrane proteins. Supported by a Dutch Research Council (NWO) AES grant, the...
Leyden Labs secures €20 Million EIB funding to strengthen pandemic preparedness
Leyden Labs has secured €20 million in financing from the European Investment Bank (EIB), supported by HERA Invest under the EU’s InvestEU programme. The funding will support the clinical development of Leyden Labs’ PanFlu nasal spray, an intranasal antibody therapy...
LUMC develops vaccine to unmask hidden lung cancer cells
Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung cancer (NSCLC). This vaccine aims to expose cancer cells that have evaded the immune system,...
TechTalk- Women’s Health
The May edition of TechTalk at Leiden Bio Science Park was a reminder that women’s health is not a niche. It’s a vital priority for the future of healthcare. Hosted in collaboration with Rijksmuseum Boerhaave, the session sparked conversations that continue to...